| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 41.2378 | 10 |
| GSM780708 | Untreated after 4 days (C2_1) | 36.308 | 1 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.3884 | 43 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.2657 | 38 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.9051 | 45 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.3163 | 34 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.4231 | 34 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.5979 | 25 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.6036 | 16 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.1509 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.475 | 39 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.703 | 51 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.2602 | 14 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.495 | 11 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.7832 | 31 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.8983 | 45 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.3607 | 46 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.246 | 52 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.6166 | 35 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 40.9193 | 9 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.5337 | 35 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.143 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 43.2915 | 19 |